Milestone Pharmaceuticals Inc.
MIST
$1.07
-$0.06-4.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -120.68% | -25.55% | -40.82% | -26.31% | -38.48% |
| Total Depreciation and Amortization | 103.57% | 107.41% | 8.47% | 0.00% | 7.69% |
| Total Amortization of Deferred Charges | 11.32% | 14.71% | 18.56% | 14.74% | 16.48% |
| Total Other Non-Cash Items | 175.89% | 151.97% | 134.64% | 0.76% | 4.26% |
| Change in Net Operating Assets | 88.61% | -0.79% | -98.04% | -133.17% | -267.29% |
| Cash from Operations | -80.76% | -15.06% | -86.69% | -38.90% | -107.60% |
| Capital Expenditure | -136.36% | -650.00% | -1,186.36% | 50.00% | -57.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,025.24% | -338.13% | -84.57% | -639.43% | 4.91% |
| Cash from Investing | 1,026.23% | -338.31% | -86.02% | -639.79% | 4.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 25,300.00% | 13,732.14% | 151,704.17% | 62,528.38% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 25,269.44% | 67,295.71% | 151,704.17% | 66,005.41% | 112.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,905.53% | -108.75% | 110.64% | 1,004.10% | -182.59% |